Great Lakes Advisors LLC lowered its position in CME Group Inc (NASDAQ:CME) by 17.2% during the third quarter, according to its most recent filing with the SEC. The institutional investor owned 32,923 shares of the financial services provider’s stock after selling 6,846 shares during the period. Great Lakes Advisors LLC’s holdings in CME Group were worth $5,604,000 at the end of the most recent quarter.
A number of other hedge funds have also recently made changes to their positions in the business. Belpointe Asset Management LLC acquired a new stake in shares of CME Group in the 3rd quarter worth $294,000. Morgan Stanley increased its stake in shares of CME Group by 20.5% in the 3rd quarter. Morgan Stanley now owns 1,118,708 shares of the financial services provider’s stock worth $190,415,000 after acquiring an additional 190,256 shares during the last quarter. Legal & General Group Plc increased its stake in shares of CME Group by 2.2% in the 3rd quarter. Legal & General Group Plc now owns 1,612,654 shares of the financial services provider’s stock worth $274,515,000 after acquiring an additional 34,772 shares during the last quarter. Rehmann Capital Advisory Group increased its stake in shares of CME Group by 17,847.3% in the 3rd quarter. Rehmann Capital Advisory Group now owns 280,876 shares of the financial services provider’s stock worth $1,650,000 after acquiring an additional 279,311 shares during the last quarter. Finally, Financial Enhancement Group LLC acquired a new stake in shares of CME Group in the 3rd quarter worth $393,000. Institutional investors own 84.55% of the company’s stock.
Shares of NASDAQ:CME opened at $190.08 on Friday. The company has a debt-to-equity ratio of 0.15, a current ratio of 1.09 and a quick ratio of 1.09. The stock has a market cap of $64.60 billion, a P/E ratio of 39.85, a price-to-earnings-growth ratio of 2.21 and a beta of 0.49. CME Group Inc has a 12-month low of $143.68 and a 12-month high of $197.08.
The company also recently announced a quarterly dividend, which will be paid on Thursday, December 27th. Investors of record on Monday, December 10th will be issued a dividend of $0.70 per share. This represents a $2.80 dividend on an annualized basis and a yield of 1.47%. The ex-dividend date is Friday, December 7th. CME Group’s dividend payout ratio (DPR) is 58.70%.
CME has been the subject of a number of recent research reports. BidaskClub raised CME Group from a “hold” rating to a “buy” rating in a research note on Saturday, August 18th. Deutsche Bank raised their price objective on CME Group from $205.00 to $206.00 and gave the stock a “buy” rating in a research report on Friday, November 16th. Bank of America reissued a “buy” rating and set a $200.00 price objective on shares of CME Group in a research report on Monday, November 5th. Jefferies Financial Group reissued a “buy” rating and set a $190.00 price objective on shares of CME Group in a research report on Wednesday, September 5th. Finally, Berenberg Bank raised CME Group from a “hold” rating to a “buy” rating and set a $220.00 price objective for the company in a research report on Tuesday, November 20th. Six research analysts have rated the stock with a hold rating, ten have given a buy rating and one has assigned a strong buy rating to the stock. The stock presently has a consensus rating of “Buy” and a consensus price target of $191.80.
In related news, Director Martin J. Gepsman sold 300 shares of the firm’s stock in a transaction dated Thursday, September 13th. The stock was sold at an average price of $172.30, for a total transaction of $51,690.00. Following the completion of the transaction, the director now directly owns 42,912 shares in the company, valued at approximately $7,393,737.60. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Julie Winkler sold 5,847 shares of the firm’s stock in a transaction dated Friday, November 16th. The shares were sold at an average price of $195.01, for a total value of $1,140,223.47. Following the transaction, the insider now owns 24,255 shares of the company’s stock, valued at $4,729,967.55. The disclosure for this sale can be found here. Insiders have sold a total of 44,419 shares of company stock valued at $8,193,732 over the last 90 days. 0.43% of the stock is currently owned by company insiders.
TRADEMARK VIOLATION WARNING: This report was originally published by Community Financial News and is owned by of Community Financial News. If you are viewing this report on another website, it was illegally stolen and republished in violation of US and international trademark & copyright laws. The original version of this report can be accessed at https://www.com-unik.info/2018/12/02/great-lakes-advisors-llc-decreases-holdings-in-cme-group-inc-cme.html.
CME Group Company Profile
CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals.
Further Reading: How to Invest in the Dividend Aristocrat Index
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.